Keywords :
Clinical trials; Collision mitigation; Commercialization; Costs; Delay; Drugs; Food technology; Investments; Pharmaceutical technology; Safety; Biotechnology; Device Approval; Drug Approval; Insurance, Health, Reimbursement; Reimbursement Mechanisms; Research; United States; United States Food and Drug Administration;
